Gregory R. Pond

699 Concession St
Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 390 publications

ASO Visual Abstract: Two-Year Outcomes After Direct-to-Surgery in Good Prognosis Margin-Clear Stage II or III Rectal Cancer-The QuickSilver Study.

ASO Visual Abstract: Two-Year Outcomes After Direct-to-Surgery in Good Prognosis Margin-Clear Stage II or III Rectal Cancer-The QuickSilver Study.

Journal: Annals of surgical oncology

Published: July 04, 2026

Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer.

Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer.

Journal: NEJM evidence

Published: May 26, 2026

Stereotactic Prostate Cancer Ablative Re-Irradiation: A Systematic Review and Meta-Analysis (SPARE).

Stereotactic Prostate Cancer Ablative Re-Irradiation: A Systematic Review and Meta-Analysis (SPARE).

Journal: The Prostate

Published: May 18, 2026

Incidence and Management Trends in Advanced Head and Neck Non-Melanoma Skin Cancer in Ontario.

Incidence and Management Trends in Advanced Head and Neck Non-Melanoma Skin Cancer in Ontario.

Journal: Current oncology (Toronto, Ont.)

Published: March 28, 2026

Correction: Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based study.

Correction: Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based study.

Journal: Blood cancer journal

Published: March 02, 2026

Assessment of Risks and Outcomes of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Recipients Including Potentially Undiagnosed Cases-A Multicenter Canadian Study.

Assessment of Risks and Outcomes of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Recipients Including Potentially Undiagnosed Cases-A Multicenter Canadian Study.

Journal: Current oncology (Toronto, Ont.)

Published: March 01, 2026

A Randomized Trial Evaluating Personalized Versus Guideline-Based Well Follow-Up Strategies for Patients with Early Breast Cancer: Feasibility Outcomes.

A Randomized Trial Evaluating Personalized Versus Guideline-Based Well Follow-Up Strategies for Patients with Early Breast Cancer: Feasibility Outcomes.

Journal: Current oncology (Toronto, Ont.)

Published: February 20, 2026

International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR.

International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 23, 2026

Two-Year Outcomes after Direct-to-Surgery in Good Prognosis Margin-Clear Stage II or III Rectal Cancer: The QuickSilver Study.

Two-Year Outcomes after Direct-to-Surgery in Good Prognosis Margin-Clear Stage II or III Rectal Cancer: The QuickSilver Study.

Journal: Annals of surgical oncology

Published: January 02, 2026

Pre-operative positron emission tomography scan is associated with lower rates of adjuvant treatment in surgically treated patients with cervical cancer: a 4C Working Group study.

Pre-operative positron emission tomography scan is associated with lower rates of adjuvant treatment in surgically treated patients with cervical cancer: a 4C Working Group study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: December 08, 2025

Second primary malignancy in multiple myeloma: does a prior malignancy matter?

Second primary malignancy in multiple myeloma: does a prior malignancy matter?

Journal: Haematologica

Published: November 30, 2025

Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study.

Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study.

Journal: Journal of medical Internet research

Published: November 29, 2025

Showing 1-12 of 390

Last Updated: 09/26/2026